Autopsy report · NCT00510471
Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
Cause of deathNo reason given
Life of this trial
- Registered 3 months after it had already started.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Genitope Corporation
- Sponsor type
- Industry
- Conditions
- Non-Hodgkin's Lymphoma
- Interventions
- autologous immunoglobulin idiotype-KLH conjugate vaccine
- Sites
- 9
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.